Article Versions Notes

Brancati S, Gozzo L, Romano GL, Vetro C, Dulcamare I, Maugeri C, Parisi M, Longo L, Vitale DC, Di Raimondo F, et al. Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? Cancers. 2022; 14(1):22. https://doi.org/10.3390/cancers14010022

Brancati, Serena, Lucia Gozzo, Giovanni Luca Romano, Calogero Vetro, Ilaria Dulcamare, Cinzia Maugeri, Marina Parisi, Laura Longo, Daniela Cristina Vitale, Francesco Di Raimondo, and et al. 2022. "Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?" Cancers 14, no. 1: 22. https://doi.org/10.3390/cancers14010022

Brancati, S., Gozzo, L., Romano, G. L., Vetro, C., Dulcamare, I., Maugeri, C., Parisi, M., Longo, L., Vitale, D. C., Di Raimondo, F., & Drago, F. (2022). Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? Cancers, 14(1), 22. https://doi.org/10.3390/cancers14010022